en/health – 36. oldal
- GLP-1 Weight-Loss Drugs: How They’re Reshaping Fitness, Addiction Care, and Safety Concerns 2026-01-09
GLP-1 medications are changing more than waistlines: they’re influencing gym habits, sparking new research into addiction treatment, and raising fresh safety and misuse concerns. Here’s what the latest headlines suggest—and what to consider if you’re thinking about these drugs.
- Weight Loss in 2026: Setting Safer Goals in the Age of GLP-1 Drugs, Gym Shifts, and Celebrity Transformations 2026-01-09
Weight loss is a popular New Year goal, but today’s landscape includes GLP-1 medications, changing gym habits, and headline-driven expectations. Here’s a practical, health-first guide to setting realistic goals and choosing safe strategies.
- Weight-Loss Injections in 2026: Big Results, Bigger Questions About What Comes After 2026-01-09
GLP-1 weight-loss injections can deliver rapid weight loss, but many people face side effects, muscle loss risk, and weight regain after stopping. Here’s what recent reporting and analysis suggest—and how to plan for sustainable results.
- What Happens After You Stop GLP-1 Weight-Loss Drugs—and How to Maintain Results 2026-01-09
New research suggests many people regain weight quickly after discontinuing GLP-1 anti-obesity medications, which can also blunt earlier health improvements. Here’s why it happens and how to plan for long-term maintenance with your clinician.
- What Happens When You Stop GLP-1 Weight-Loss Drugs: Regain, Maintenance, and Smarter Next Steps 2026-01-09
New research suggests many people regain weight soon after stopping GLP-1 weight-loss medications, with some health benefits fading too. Here’s why it happens and how to plan for safer, longer-term results.
- What Happens When You Stop GLP-1 Weight-Loss Drugs—and What New Research Suggests Is Coming Next 2026-01-08
New reports suggest many people regain weight quickly after stopping GLP-1-based weight-loss medications, sometimes alongside worsening cardiometabolic markers. Here’s what the rebound means, why it happens, and how emerging therapies may aim to improve long-term results.
- Weight-Loss Drugs in the UK: What Happens When You Stop—and How to Stay Healthy 2026-01-08
Use of prescription weight-loss injections is rising in Great Britain, but stopping them often leads to rapid weight regain. Here’s what the evidence suggests and how to reduce health and nutrition risks with a practical support plan.
- What Happens After You Stop Weight-Loss Injections: Regain Risk, Health Rebound, and How to Plan 2026-01-08
Research suggests many people regain weight after stopping GLP-1-style weight-loss injections, sometimes within two years, alongside a reversal of some health improvements. This guide explains why it happens and how to reduce the risk with a structured off-ramp plan.
- Weight-Loss Drugs: Why Nutrition Support and Long-Term Plans Matter 2026-01-08
New reporting and research suggest that people using GLP-1 weight-loss drugs may face avoidable nutrient gaps and rapid rebound weight after stopping—especially without structured follow-up. Here’s what to monitor and how to build a sustainable plan with your clinician.
- Weight-Loss Drugs and Nutrition: Why Support Matters for Healthier Results 2026-01-08
As weight-loss medications become more common, experts warn that reduced appetite and limited follow-up can increase the risk of nutritional deficiencies. Here’s what to watch for and how to use these treatments more safely and sustainably.